Skip navigation

BioWednesday London: Securing Investment and Partners in the US

This event has reached capacity and registration is now closed. To be added to the waiting list, please email

Gowling WLG, 4 More London Riverside, London. SE1 2AU
07 September 2016
North America, is although, not exclusively a high priority for most biotech and healthcare companies when it comes to raising investment, partnering deals and securing R&D contracts remains.

This BioWednesday will give attendees the opportunity to get updated on where the BIO Dollars are flowing from when it comes to Pharma R&D budgets, venture investment and public markets; to be alerted to what to look out for on US term sheets and to receive some practical advice from a range of One Nucleus Partners as many start to formulate their strategies to get the best ROI from JP Morgan and Biotech Showcase in San Francisco in January 2017

18.00 - Registration and networking

18.30  - Welcome from the Host and Chair 

18.40  - Where are investors and Pharma placing their investment?
Mike Ward, Scrip Intelligence & Datamonitor
Click here to view the presentation

19.00  - Speaking the same language as US investors and buyers
Patrick Duxbury and Chris Towle, Gowling WLG
Click here to view the presentation

19.20  - Practical Considerations wen approaching US investors and partners

Chair: Tony Jones, One Nucleus 

Mary Clark and Eva Hass, Hume Brophy
Keith Martin and Stephane Verdood, Apitope
  - Closing remarks

19.45  - Networking over drinks & canapes

21.00  - Close


Members - free 
Non-member - £50 + VAT
Academics and students - contact

Title: BioWednesday London: Securing Investment and Partners in the US
Start: 2016-09-07 18:00:00Z
End: 2016-09-07 21:00:00Z